FIELD: medicine.
SUBSTANCE: invention concerns area of medicine and concerns the therapeutic agent for treatment of diseases related to children's chronic arthritic diseases, for example, actually children's chronic arthritic diseases, Still's disease and similar to it, including an antagonist of the interleukin-6 IL-6 receptor as an active ingredient, humanised antibody PM-1. Advantage of the invention consists in efficiency increase.
EFFECT: efficiency increase.
5 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR TREATING DISEASES RELATED TO JUVENILE CHRONIC ARTHRITIS | 2002 |
|
RU2541165C2 |
| METHOD OF TREATING INTERLEUKIN-6-DEPENDENT DISEASES | 2004 |
|
RU2509574C2 |
| PROPHYLACTIC DRUG FOR VASCULITIS | 2004 |
|
RU2379054C2 |
| THERAPEUTIC AGENT IN SPINAL MARROW INJURY CONTAINING INTERLEUKINE-6 ANTAGONIST | 2004 |
|
RU2358761C2 |
| CHRONIC REJECTION INHIBITOR | 2008 |
|
RU2450829C2 |
| DRUGS AGAINST CHRONIC RHEUMATIC ARTHRITIS CONTAINING ANTAGONIST OF IL-6 AS EFFECTIVE COMPONENT | 1995 |
|
RU2147443C1 |
| PROPHYLACTIC OR THERAPEUTIC AGENT FOR TREATING INFLAMMATORY INTESTINAL DISEASES CONTAINING IL-6 ANTAGONIST AS AN ACTIVE INGREDIENT | 1999 |
|
RU2195960C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| THERAPEUTIC AGENT USED FOR GRAFT-VERSUS-HOST DISEASE, CONTAINING INTERLEUKIN-6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT | 2008 |
|
RU2490025C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
